In orthopaedics, Johnson & Johnson MedTech focuses on joint reconstruction, robotics, spine, sports, trauma, and extremities. Credit: Ahmet Misirligul / Shutterstock.

Johnson & Johnson MedTech has announced an exclusive commercial distribution agreement in the US with Responsive Arthroscopy for expanding sports soft tissue repair solutions.

This collaboration aims to strengthen Johnson & Johnson MedTech’s sports platform and will deliver advanced soft tissue repair solutions for foot, shoulder and ankle procedures.

Go deeper with GlobalData

Data Insights

The gold standard of business intelligence.

Find out more

It will enhance Johnson & Johnson MedTech’s soft tissue portfolio to meet the growing demand for advanced solutions in the market.

This agreement will see the combination of Johnson & Johnson MedTech’s knowledge in orthopaedic innovation with the advanced technologies of responsive arthroscopy to provide a comprehensive set of tools to healthcare providers for addressing evolving needs.

Johnson & Johnson MedTech Orthopaedics company group chairman Aldo Denti said “Our relationship with Responsive Arthroscopy is a significant step in expanding our leadership in orthopaedics and advancing our sports soft tissue offerings.

“This collaboration allows us to deliver a broader range of cutting-edge tools that empower surgeons in shoulder, foot and ankle procedures. We’re excited to drive value in this rapidly growing segment and remain committed to advancing patient care in meaningful ways.”

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

In orthopaedics, the company focuses on robotics, joint reconstruction, spine, sports, trauma, and extremities, leveraging deep expertise to develop next-generation medical technology solutions.

This month, after years of teasing an entry into the surgical robotics space, Johnson & Johnson MedTech completed a major step in progressing its system, winning an investigational device exemption (IDE) from the US Food and Drug Administration (FDA) for the technology.

The IDE will allow the company to conduct clinical trials at US sites with the robotic surgical system called Ottava.